glp-1 side effects pancreatitis New data links agonists for weight loss with higher risk for pancreatitis, GI events Struggling with GLP-1 therapy side
Description
Cureus, 14 (11)
Since the mean/median duration for each of these studies was 100,000 patients prescribed a GLP-1RA, after propensity matching, there was reduced risk for PDAC during a 5-year observation period for GLP-1RA users compared to six categories of commonly used diabetes medication classes 44
75% of prescriptions linked to supplements were GP-guided in 2025
However, individuals who have type 2 diabetes alongside a need to minimise weight gain or promote weight loss may benefit from GLP-1/GIP therapy and its dual impact on type 2 diabetes management and weight loss
